WallStreetZenWallStreetZen

NASDAQ: CASI
Casi Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CASI past revenue growth

How has CASI's revenue growth performed historically?
Company
-21.41%
Industry
148.4%
Market
16.96%
CASI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CASI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CASI earnings and revenue history

Current Revenue
$33.9M
Current Earnings
-$27.0M
Current Profit Margin
-79.6%

CASI Return on Equity

Current Company
-86.4%
Current Industry
-63.5%
Current Market
188%
CASI's Return on Equity (-86.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CASI announces earnings.

CASI Return on Assets

Current Company
-34.2%
Current Industry
2.9%
CASI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CASI Return on Capital Employed

Current Company
-46.15%
Current Industry
19.5%
CASI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CASI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CASI$33.88M-$22.29M-$26.96M+69.23%N/A
VIRX$0.00-$46.86M-$51.06M-100.00%N/A
TARA$0.00-$40.08M-$40.42MN/AN/A
ACHL$0.00-$64.46M-$69.67MN/AN/A
IPA$17.41M-$7.05M-$10.48M+68.89%N/A
View Top Biotech Stocks

Casi Pharmaceuticals Earnings & Revenue FAQ

What were CASI's earnings last quarter?

Casi Pharmaceuticals (NASDAQ: CASI) reported Q4 2023 earnings per share (EPS) of -$0.46, up 68.06% year over year. Total Casi Pharmaceuticals earnings for the quarter were -$6.08 million. In the same quarter last year, Casi Pharmaceuticals's earnings per share (EPS) was -$1.44.

If you're new to stock investing, here's how to buy Casi Pharmaceuticals stock.

What was CASI's earnings growth in the past year?

As of Q2 2024, Casi Pharmaceuticals's earnings has grown year over year. Casi Pharmaceuticals's earnings in the past year totalled -$26.96 million.

What was CASI's revenue last quarter?

Casi Pharmaceuticals (NASDAQ: CASI) reported Q4 2023 revenue of $6.87 million up 54.95% year over year. In the same quarter last year, Casi Pharmaceuticals's revenue was $15.26 million.

What was CASI's revenue growth in the past year?

As of Q2 2024, Casi Pharmaceuticals's revenue has grown -21.41% year over year. This is 169.81 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Casi Pharmaceuticals's revenue in the past year totalled $33.88 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.